Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China reports embryo cloning advantage:

This article was originally published in Clinica

Executive Summary

China could be leading the race to create the world's first stem cell lines, after reportedly succeeding in cloning human embryos and harvesting stem cells since 1999. According to the The Wall Street Journal, Professor Lu Guangxiu of Xiangya Medical College, in Changsa, claims that her team have been cloning human embryos for two years, with some 5% surviving long enough to allow stem cell harvesting. US researchers had claimed the world's first cloned embryo last year.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065098

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel